Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

IDEXX Laboratories Inc (NASDAQ:IDXX)

72.73
Delayed Data
As of Jul 31
 +1.39 / +1.95%
Today’s Change
56.75
Today|||52-Week Range
84.26
-1.90%
Year-to-Date

Today’s Trading

Previous close71.34
Today’s open71.95
Day’s range71.62 - 73.77
Volume1,565,227
Average volume (3 months)906,470
Market cap$6.2B
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)+2.87%
Earnings growth (this year)+4.98%
Earnings growth (next 5 years)+12.50%
Revenue growth (last year)+7.90%
P/E ratio39.7
Price/Sales5.06
Price/Book53.08

Competitors

 Today’s
change
Today’s
% change
SGENSeattle Genetics Inc+0.53+1.12%
TAROTaro Pharmaceutical ...+0.75+0.54%
HZNPHorizon Pharma PLC+0.54+1.49%
ICPTIntercept Pharmaceut...+2.01+0.77%
Data as of 4:02pm ET, 07/31/2015

Financials

Next reporting dateOctober 23, 2015
EPS forecast (this quarter)$0.55
Annual revenue (last year)$1.5B
Annual profit (last year)$181.9M
Net profit margin12.24%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Jonathan W. Ayers
Chief Financial Officer, Treasurer &
Executive VP
Brian P. McKeon
Corporate headquarters
Westbrook, Maine

Forecasts